Novartis in discussions to help produce COVID-19 vaccines, tests Reuters Jan 28, 2021 Novartis last year agreed to license two of Molecular Partners’ antiviral drugs that it hopes to use to treat COVID-19 patients
Cipla launches rapid antigen detection test to diagnose COVID-19 EP News Bureau Dec 16, 2020 The test will be marketed under the brand name CIPtest
